GW Pharma plans to expand marijuana operations in UK

One of the world’s biggest marijuanas companies – GW Phamaceuticals – is poised to get even bigger.

The company announced that it’s planning an expansion in the United Kingdom, including the cultivation and processing of non-psychoactive cannabis, The Telegraph of London reported.

GW Pharma’s plan stems from “anticipated demand” for a CBD-based drug, Sativex, designed to help treat epilepsy, a company official told the newspaper.

The Cambridge, England-based company is planning to invest 50 million British pounds ($64.6 million) on the expansion over the next three years and will hire 70 new staffers to increase its U.K.

…

GW Pharma plans to expand marijuana operations in UK is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs

Read More: GW Pharma plans to expand marijuana operations in UK